Skip to main content
NewslettersWatchlist

Creative Medical Technology Holdings Inc(CELZ-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Creative Medical Technology Holdings Inc

211 E. OSBORN ROAD
PHOENIX AZ 85012 USA
P: 480-399-2822
http://www.creativemedicaltechnology.com

Profile

Creative Medical Technology Holdings Inc. is a commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics. Creative Medical Technology Holdings Inc. is based in PHOENIX.

Key Executives

NameTitle
Timothy WarbingtonCEO/Chairman of the Board/Director
Donald DickersonCFO/Chief Accounting Officer/Director

More from The Globe

ReconAfrica agrees to pay out more than $10-million over allegedly misleading disclosure
ReconAfrica oil drilling site in Namibia for Geoffrey York and Emma Graney story.
Dividend investing has lost its mojo. Here’s why – and how to adapt
Ian McGugan
The Globe Investing Club 2024: Let the competition begin!
opinion
Here’s the real reason your Canadian stocks can’t keep up
Tim Shufelt
Dow ends above 40,000 milestone, TSX also at fresh record high
Traders work on the floor of the New York Stock Exchange (NYSE) on May 16.
number cruncher
U.S technology stocks with earnings and price momentum
For Number Cruncher column in Globe Investor/ROB only.
Lightspeed Commerce stock soars on better-than-expected profit forecast
Lightspeed Commerce Inc. CEO Dax Dasilva poses in the company's offices in Montreal, Wednesday, May 8, 2024. THE CANADIAN PRESS/Christinne Muschi
The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings
The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.